Search Results

ANNUAL INDEX 2005.

Subjects: INDEXES; DRUG side effects

• Source: Reactions Weekly; 2005 Annual Index (1033-1082), p1-35, 35p

Record details

New Solutions for Type 2 Diabetes Mellitus: The Role of Pioglitazone.

• Authors : Grossman, L.D.¹

Subjects: *TREATMENT of diabetes; *INSULIN resistance; *HYPOGLYCEMIC agentsCANADA

• Source: PharmacoEconomics. 2002 Supplement 1, Vol. 20 Issue 1, p1-9. 9p. 1 Chart.

Record details

Cost Effectiveness of Combination Therapy with Pioglitazone for Type 2 Diabetes Mellitus from a German Statutory Healthcare Perspective.

• Authors : Neeser, Kurt¹; Lübben, Georg²; Siebert, Uwe^3,4

Subjects: *THERAPEUTICS; *DRUGS; *COST effectivenessUNITED States

• Source: PharmacoEconomics. 2004, Vol. 22 Issue 5, p321-341. 21p. 3 Diagrams, 6 Charts, 2 Graphs.

Record details

Economic Evaluation of Pioglitazone Hydrochloride in the Management of Type 2 Diabetes Mellitus in Canada.

• Authors : Coyle, D.¹; Palmer, A.J.²; Tam, R.³

Subjects: *HYPOGLYCEMIC agents; *TREATMENT of diabetes; *COST effectivenessCANADA

• Source: PharmacoEconomics. 2002 Supplement 1, Vol. 20 Issue 1, p31-42. 12p. 4 Diagrams, 5 Charts.

Record details

Applications of Economic Models in Healthcare: The Introduction of Pioglitazone in Sweden.

• Authors : Henriksson, F.¹

Subjects: *MEDICAL care costs; *TREATMENT of diabetes; *HYPOGLYCEMIC agentsSWEDEN

• Source: PharmacoEconomics. 2002 Supplement 1, Vol. 20 Issue 1, p43-53. 11p. 6 Charts, 1 Graph.

Record details

Antidiabetic Drugs Present and Future: Will Improving Insulin Resistance Benefit Cardiovascular Risk in Type 2 Diabetes Mellitus?

• Authors : Campbell, I.W.¹

Subjects: *HYPOGLYCEMIC agents; *TYPE 2 diabetes; *INSULIN resistance

• Source: Drugs. Nov2000, Vol. 60 Issue 5, p1017-1028. 12p.

Record details